Overview

The ALP Protocols

ALP Life Sciences (ALP) was founded as a lipid membrane research project based on the discovery of new and emerging lipid science. The primary ALP focus is on innovative and novel approaches to nutritional medicine. The core purpose and mission are to create nutrition-based protocols to remodel lipid membranes to improve human health.

Good nutritional science and interventions have untapped potential to increase the efficacy of traditional medical interventions. ALP is building evidence-based bridges between nutritional medicine and tractional medicine.

A nutritional medicine renaissance is underway. ALP is just a part of this important trend that is gathering momentum. The results of the original ALP funded research validated the key ALP hypothesis. The research was conducted at a major university nutrition department by a world-class and highly respected PhD nutritionist with lipid membrane expertise. The early ALP research has led to the development of two lipid membrane-focused protocols.

The ALP protocols, based on generally recognized as safe (GRAS) compounds and dosing, utilize important emerging omega 3 and specialized lipid membrane science. The core ALP mission is advancing precision lipid intervention protocols with the ability to remodel lipid membranes. In short, 1) prevention of inflammatory conditions, and 2) the removal of environmental toxins are the ALP objectives.

ALP is focused on scientists, physicians, and patients that are proactive regarding health. And patients that appreciate the emerging lipid science and evidence for nutritional interventions from nutrition experts. If you are still reading and investigating ALP protocols and products, you are likely one of those interested in optimizing your personal and family’s health and lipid membrane function and/or your patient’s.

  1. The ALP Omega-3 Protocol (O3P): A science-based intervention method using two forms of omega 3s, fish oil triglycerides (TAG) and krill oil phospholipids (PL) supplements. The objective of the protocol is to provide a simple method to manage and optimize the omega-3 index (O3i). Lipids are key building blocks of cells. Your O3i controls what enters and leaves your cells, organelles, lysosomes, and many other lipid structures.
  2. The ALP LipoVeson™ Protocol: The novel ALP “LipoVeson™” Protocol is based on a novel method to remodel lipid membranes by triggering compound release and capture for removal. The implications for human health are significant. The objective is to reduce inflammatory lipids (and other compounds) in membranes for prevention, treatment, and diagnostics. The ALP LipoVeson™ protocol research continues. Stay tuned...